Overview
Als Therapy Development Foundation, Inc.
The ALS Therapy Development is a not-for profit biotechnology company that conducts medical research on amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. The degenerative disease progressively attacks neurons in the brain and spinal cord. When these neurons can no longer send impulses to the body's voluntary muscles (due to ALS), the muscles begin to waste away. The organization focuses on drug discovery and development for a
...
Read More cure for ALS, both independently and through collaborations with drug and research entities. Director James Heywood established the company in 1999.
Read Less
Read More cure for ALS, both independently and through collaborations with drug and research entities. Director James Heywood established the company in 1999.
Read Less
Steve Perrin
See more contacts
Scientific Research and Development Services
,
Professional, Scientific, and Technical Services
,
Medical research
,
Noncommercial biological research organization
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
480 Arsenal St Watertown, MA, 02472-2805 United States
(617) 441-7200
30
30
Actual
30
Actual
$13.13 million
Actual
DEC
1999
1.0
2.4
2.4
Is this your business? Contact us to understand how D&B calculated your company’s specific ESG Ranking, provide new or updated information to ensure your company’s ESG Ranking remains accurate and up to date, or dispute your current ranking.
Contacts
Get in Touch with 1 Principals* and 93 Contacts
A D&B Hoovers Subscription is your foot in the door to Als Therapy Development Foundation, Inc. contact information.
-
Steve PerrinChief Executive Officer
-
Alan GillVice President
-
Alessandro CaloDevelopment Institute
-
Alicia FavicchioEvent And Program Manager
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Sales in USD
Annual Sales 2019
$13.13 million
USD
Actual